Prions cause neurodegenerative diseases in humans and animals like cows, sheep, or deer. In most cases, humans or animals get sick sporadically, when, for unknown reasons, normal proteins in the brain called PrPc change to harmful prions (called PrPSc).

The PrPSc proteins then cause severe degeneration of the brain that kills the victims within a matter of months. There are no cures or therapies for prion diseases. The most common human prion disease is sporadic Creutzfeld-Jacob Disease, or sCJD. Scientists still understand little about why and how in some cases normal proteins change to prions and destroy the brain.

All patients die, most of them within a few months, but there are differences between individual cases. The hope is that understanding the differences between individual cases might eventually provide some insight into the causes of the disease and suggest ways to treat it.

To catalogue and examine those differences, it is important to come up with standard assays that allow meaningful comparisons. Markus Glatzel (Hamburg University) and colleagues have developed such an assay.

Applying it to 50 postmortem samples from patients with sCJD reveals substantial differences in molecular pathology, suggesting that this approach could indeed help to understand this mysterious and devastating disease.

Citation:
Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, et al. (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3(2): e14.

Link to article:
dx.doi.org/10.1371/journal.pmed.0030014

PUBLIC LIBRARY OF SCIENCE
European Bioinformatics Institute,
Wellcome Trust Genome Campus,
CB10 1DS,
UK
http://www.plos.org

About the PUBLIC LIBRARY OF SCIENCE

PLoS is a nonprofit organization of scientists whose aim is to make the world's scientific and medical research literature a public resource. We are funded by a grant from the Gordon and Betty Moore Foundation to develop a publishing program based on the Open Access business model, whereby the costs of publication are paid upfront so that anyone with an internet connection can have access to the content, in a free and unrestricted manner. Our immediate goal is to launch two top-tier journals - PLoS Biology (in October, 2003) and PLoS Medicine (in 2004).